Civco Radiotherapy recently received FDA 510(k) clearance and CE Mark approval for its Solstice SRS Immobilization System.
The Solstice SRS Immobilization System has a unique corrective pitch capability and positioning flexibility. It also features customizable components that are able to create a comfortable head and neck immobilization system for radiotherapy treatments.
“The Solstice SRS Immobilization System is the only midline thermoplastic mask system on the market with variable pitch capability, increasing setup options in CT simulation and allowing positioning flexibility during treatment,” John Steffen, director of product management at Civco, said in a press release. “We are excited that clearance in the U.S. and EU CE marking opens opportunities for us to provide this unique solution to radiotherapy clinics to help improve patient outcomes.”
Civco’s system is made from a carbon fiber head support, a customizable cushion and dedicated thermoplastic mask that is designed for secure and simple attachment.